Estimation of Candida albicans ABC transporter behaviour in real-time via fluorescence

Estimation of Candida albicans ABC transporter behaviour in real-time via fluorescence

We present a fluorometric method for determining ABC transporter activity in the pathogenic fungus Candida albicans during different growth phases and in response to glucose. The carbocyanine dye diS-C3(3) was previously used to monitor plasma membrane potentials and test the influence of surface-ac...

Full description

Bibliographic Details
Main Authors:	Joanna eSzczepaniak, Marcin eŁukaszewicz, Anna eKrasowska
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-12-01
Series:	Frontiers in Microbiology
Subjects:	Candida albicans CDR diS-C3(3) fluorescence protein localization imaging kinetics of efflux pump activity
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01382/full

Similar Items

Detection of inhibitors of Candida albicans Cdr transporters using a diS-C3(3) fluorescence
by: Joanna eSzczepaniak, et al.
Published: (2015-03-01)

Antifungal Styryloquinolines as <i>Candida albicans</i> Efflux Pump Inhibitors: Styryloquinolines are ABC Transporter Inhibitors
by: Wioleta Cieslik, et al.
Published: (2020-01-01)

Octyl gallate reduces ABC multidrug transporter CaCdr1p expression and leads to its mislocalisation in azole-resistant clinical isolates of Candida albicans
by: Shweta Singh, et al.
Published: (2020-09-01)

Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1
by: Hongkang Wang, et al.
Published: (2022-12-01)

Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills <i>Candida albicans</i>
by: Jakub Suchodolski, et al.
Published: (2021-05-01)

The Role of Ergosterol and Sphingolipids in the Localization and Activity of <i>Candida albicans</i>’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p
by: Aneta K. Urbanek, et al.
Published: (2022-09-01)

Decreasing Cell Population of Individual Candida Species Does Not Impair the Virulence of Candida albicans and Candida glabrata Mixed Biofilms
by: Qianqian Li, et al.
Published: (2019-07-01)

Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1
by: Florimar Gil, et al.
Published: (2022-10-01)

Evaluation of Susceptibility of Strains of Candida Albicans Isolated from AIDS Patients to Fluconazole and Determination of CDR2 Resistance Gene in Resistant Strains by RT-PCR Method
by: E Farahbakhsh, et al.
Published: (2011-08-01)

Molecular dissection studies of TAC1, a transcription activator of Candida drug resistance genes of the human pathogenic fungus Candida albicans
by: Tushar Jain, et al.
Published: (2023-07-01)

Effect of biogenic selenium nanoparticles on ERG11 and CDR1 gene expression in both fluconazole-resistant and -susceptible Candida albicans isolates
by: Nasrin Parsamehr, et al.
Published: (2017-09-01)

Combination Effect of Novel Bimetallic Ag-Ni Nanoparticles with Fluconazole against <i>Candida albicans</i>
by: Majid Rasool Kamli, et al.
Published: (2022-07-01)

Directed Mutational Strategies Reveal Drug Binding and Transport by the MDR Transporters of <i>Candida albicans</i>
by: Atanu Banerjee, et al.
Published: (2021-01-01)

Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11
by: Chanika Maenchantrarath, et al.
Published: (2022-06-01)

Effect of Allium cepa loaded polyacrylonitrile and polyvinyl pyrrolidone nanofibers on Candida albicans growth and the expression of CDR1 and CDR2 genes
by: Azam Nademi, et al.
Published: (2021-12-01)

Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates
by: Amira M. El-Ganiny, et al.
Published: (2022-03-01)

Plasma Membrane Potential of <i>Candida albicans</i> Measured by Di-4-ANEPPS Fluorescence Depends on Growth Phase and Regulatory Factors
by: Jakub Suchodolski, et al.
Published: (2019-04-01)

Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant Candida albicans by Competitively Inhibiting Efflux Pump
by: Jiali Xu, et al.
Published: (2019-06-01)

Metabolic fitness of Candida albicans is indispensable for functional drug efflux, ergosterol, and chitin biosynthesis
by: Sandeep Hans, et al.
Published: (2020-09-01)

Reversal of Azole Resistance in <i>Candida albicans</i> by Human Neutrophil Peptide
by: Mohammad Imran Khan, et al.
Published: (2023-02-01)

<i>CDR1, CDR2, MDR1</i> and <i>ERG11</i> expression in azole resistant <i>Сandida albicans</i> isolated from HIV-infected patients in city of Moscow
by: A. D. Voropaev, et al.
Published: (2022-11-01)

Upc2-mediated mechanisms of azole resistance in Candida auris
by: Jizhou Li, et al.
Published: (2024-02-01)

Detection of Phospholipase Activity in Candida albicans Isolates
by: Sevtap ARIKAN, et al.
Published: (1998-12-01)

Prevalencia de Candida albicans y Candida no albicans en diferentes muestras clínicas: Período 1999-2001 Prevalence of Candida albicansand Candida no albicans inclinical samples during 1999-2001
by: M.T. Mujica, et al.
Published: (2004-09-01)

Overcoming Drug Resistance in a Clinical <i>C. albicans</i> Strain Using Photoactivated Curcumin as an Adjuvant
by: Carmen-Ecaterina Leferman, et al.
Published: (2023-07-01)

A New Endogenous Overexpression System of Multidrug Transporters of Candida albicans Suitable for Structural and Functional Studies
by: Atanu eBanerjee, et al.
Published: (2016-03-01)

Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
by: Elias Seyoum, et al.
Published: (2020-03-01)

Oral candidosis by Candida albicans in normal and xerostomic mice Candidose oral por Candida albicans em camundongos normais e xerostômicos
by: Marilda Aparecida Gonçalves Totti, et al.
Published: (2004-09-01)

Evaluation of Diverse Phenotypic Methods for Differenting between Candida dubliniensis and Candida albicans
by: Dayana Camacho, et al.
Published: (2012-01-01)

Filamentous Non-albicans Candida Species Adhere to Candida albicans and Benefit From Dual Biofilm Growth
by: Ruvini U. Pathirana, et al.
Published: (2019-05-01)

Candidemia – Changing trends from Candida albicans to non-albicans Candida from a tertiary care center in western UP, India
by: Shariq Ahmed, et al.
Published: (2020-01-01)

An expanded toolkit of drug resistance cassettes for Candida glabrata, Candida auris, and Candida albicans leads to new insights into the ergosterol pathway
by: Justin B. Gregor, et al.
Published: (2023-12-01)

Immune response to Candida albicans <br> Resposta imune a Candida albicans
by: Luis Carlos Jabur Gaziri, et al.
Published: (2008-10-01)

Espondilodiscitis por Candida albicans Candida albicans spondylodiscitis: Diagnosis and Treatment
by: Silvina De Luca, et al.
Published: (2008-03-01)

A study of Candida albicans and non-albicans Candida species isolated from various clinical samples and their antifungal susceptibility pattern
by: Ratna Shukla, et al.
Published: (2020-01-01)

Serotyping of Candida albicans isolated from clinical specimens
by: Maria L. Martinez Batista, et al.
Published: (1990-03-01)

Glucose Tolerance in Pregnant Women Inflicted with Candida Albicans
by: Tarik Hovthy A.T. AL-Khayat, et al.
Published: (2009-06-01)

Candida albicans Hyphae: From Growth Initiation to Invasion
by: Jigar V. Desai
Published: (2018-01-01)

Enhanced susceptibility of Candida albicans to chlorhexidine under anoxia
by: Andressa Marafon Semprebom, et al.
Published: (2015-12-01)

Effects of ozonated water on Candida albicans oral isolates
by: Ivan da Silva Faria, et al.
Published: (2015-11-01)